Director at Foresight (NASDAQ: FRSX) reports fully vested stock options

Rhea-AI Filing Summary

Foresight Autonomous Holdings Ltd. director Zeev Levenberg reported his initial derivative holdings in stock options linked to the company’s Ordinary Shares. He holds options exercisable at $1.12 per share, covering 21,444 Ordinary Shares expiring on July 16, 2027 and 57,143 Ordinary Shares expiring on July 27, 2030.

Footnotes state these options were originally granted with an exercise price of NIS 3.50 and later converted based on a 3.119 ratio as of March 16, 2026, and are fully vested. The company’s securities trade as American Depositary Shares, where one ADS represents 90 Ordinary Shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Levenberg Zeev

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options	--	--	--
holding	Stock Options	--	--	--

Holdings After Transaction: Stock Options — 21,444 shares (Direct)

Footnotes (1)

1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. The options were granted on July 16 ,2020 and fully vested as of December 31, 2022. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on July 27, 2023 and fully vested as of June 30, 2026. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Key Figures

Option grant 1 underlying shares: 21,444 Ordinary Shares Option grant 2 underlying shares: 57,143 Ordinary Shares Exercise price (converted): $1.12 per Ordinary Share +4 more

7 metrics

Option grant 1 underlying shares 21,444 Ordinary Shares Stock options expiring July 16, 2027

Option grant 2 underlying shares 57,143 Ordinary Shares Stock options expiring July 27, 2030

Exercise price (converted) $1.12 per Ordinary Share Converted from NIS 3.50 based on 3.119 ratio

Original exercise price NIS 3.50 Per option grant footnotes

ADS ratio 1 ADS = 90 Ordinary Shares Structure of Foresight ADSs

Vesting date grant 1 December 31, 2022 First option grant fully vested

Vesting date grant 2 June 30, 2026 Second option grant fully vested

Key Terms

American Depository Shares, exercise price, fully vested, expiration date

4 terms

American Depository Shares financial

"The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares."

American depository shares are U.S.-listed securities that stand in for a foreign company’s ordinary shares, held by a U.S. bank which issues the ADS so investors can trade the foreign stock in U.S. dollars and on U.S. exchanges. Think of them like a locally wrapped version of a foreign product—easier to buy and sell at home—but they still carry risks from currency differences, foreign rules and potential limits on voting rights, so they affect access, liquidity and investment risk.

exercise price financial

"The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"The options were granted on July 16 ,2020 and fully vested as of December 31, 2022."

expiration date financial

"The ADSs have no expiration date."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Levenberg Zeev

(Last) (First) (Middle)

C/O FORESIGHT AUTONOMOUS

7 GOLDA MEIR ISRAEL

(Street)

NESS ZIONA 7414001

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	(2)	07/16/2027	Ordinary Shares(1)	21,444	$1.12(3)	D
Stock Options	(4)	07/27/2030	Ordinary Shares	57,143	$1.12(5)	D

Explanation of Responses:

1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

2. The options were granted on July 16 ,2020 and fully vested as of December 31, 2022.

3. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

4. The options were granted on July 27, 2023 and fully vested as of June 30, 2026.

5. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

	/s/ Zeev Levenberg	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What did FRSX director Zeev Levenberg report on this Form 3?

He reported his initial holdings of stock options tied to Foresight Autonomous Ordinary Shares. These options give rights to acquire 21,444 shares expiring July 16, 2027 and 57,143 shares expiring July 27, 2030, all already fully vested according to the filing’s footnotes.

How many Foresight Autonomous (FRSX) shares are covered by Levenberg’s options?

His reported stock options cover 21,444 underlying Ordinary Shares in one grant and 57,143 underlying Ordinary Shares in another. Together, they represent rights over 78,587 Ordinary Shares, subject to exercise at the stated price and before each option’s expiration date.

What is the exercise price of Zeev Levenberg’s FRSX stock options?

The options were granted with an exercise price of NIS 3.50, later converted to an exercise price of $1.12 per Ordinary Share. This conversion used a 3.119 ratio as of March 16, 2026, as specifically described in the filing’s footnotes.

When do Zeev Levenberg’s FRSX stock options expire?

One grant of options tied to 21,444 Ordinary Shares expires on July 16, 2027. A second grant tied to 57,143 Ordinary Shares expires on July 27, 2030. Both grants are reported as fully vested before these expiration dates in the Form 3 footnotes.

Are Levenberg’s FRSX options already vested according to the filing?

Yes. The filing states the July 16, 2020 grant was fully vested as of December 31, 2022. It also notes the July 27, 2023 grant was fully vested as of June 30, 2026. This means all reported option shares are currently exercisable, subject to their expiration dates.

How are Foresight Autonomous (FRSX) American Depositary Shares structured?

The filing explains that Foresight’s securities trade as American Depositary Shares, or ADSs. One ADS represents 90 Ordinary Shares, and each ADS is convertible into Ordinary Shares at any time at the holder’s election. The ADSs themselves have no stated expiration date.